A selection of injector pens for the Wegovy weight loss drug are shown in Chicago. Germany's stance on weight-loss drugs is among the region's strictest, even though the proportion of its citizens who are overweight is above the European Union average. It highlights the challenge Novo and rivals face in convincing European governments to pay for obesity drugs, which analysts say is likely to slow their take-up there. Weight-loss drugs could prolong lives and help people stay in the workforce. In the United States, the federal Medicare health plan for older Americans is prohibited from covering weight-loss drugs.

Source: CBC News July 16, 2023 02:58 UTC